These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1481031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A, Caspary L, Alexander K.
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract] [Full Text] [Related]

  • 3. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C, Hofmann U, König P, Nitsche GB.
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract] [Full Text] [Related]

  • 4. [Placebo controlled study of the effect of intravenous PGE1 on macro- and microcirculation in patients with stage III/IV arterial occlusive disease].
    Scheffler P, de la Hamette D, Leipnitz G.
    Vasa Suppl; 1991; 33():343-4. PubMed ID: 1788750
    [Abstract] [Full Text] [Related]

  • 5. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J, Caspary L, Creutzig A, Alexander K.
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Controlled long-term blood pressure measurement with intravenous prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann M, Ranft J.
    Vasa; 1991; 20(1):13-6. PubMed ID: 2031393
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K, Rogatti W, Rüttgerodt K.
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [Abstract] [Full Text] [Related]

  • 11. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
    Hinderer S, Brachmann R, Nedder KH, Bucher J, Beischer W.
    Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
    [Abstract] [Full Text] [Related]

  • 12. [Results of local thrombolysis with special reference to diabetic metabolism].
    Stiegler H, Hufen V, Weichenhain B, Standl E, Mehnert H.
    Med Klin (Munich); 1990 Apr 15; 85(4):171-5, 228. PubMed ID: 2352521
    [Abstract] [Full Text] [Related]

  • 13. [Long-term blood pressure measurements with i.v. prostaglandin E1 infusion].
    Heidrich H, Brodel C, Meuche C, Hellmann G, Ranft J.
    Vasa Suppl; 1989 Apr 15; 27():46. PubMed ID: 2623542
    [No Abstract] [Full Text] [Related]

  • 14. [Prostaglandin E1 in intermittent claudication].
    Scheffler P, de la Hamette D, Rogatti W.
    Vasa Suppl; 1992 Apr 15; 35():147-8. PubMed ID: 1481022
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of dalteparin on healing of chronic foot ulcers in diabetic patients with peripheral arterial occlusive disease: a prospective, randomized, double-blind, placebo-controlled study.
    Kalani M, Apelqvist J, Blombäck M, Brismar K, Eliasson B, Eriksson JW, Fagrell B, Hamsten A, Torffvit O, Jörneskog G.
    Diabetes Care; 2003 Sep 15; 26(9):2575-80. PubMed ID: 12941721
    [Abstract] [Full Text] [Related]

  • 20. [Effects of prostaglandin El on hemodynamics and metabolism of the extremities in healthy humans and patients with stage III and IV arterial occlusive disease].
    Rexroth W, Amendt K, Römmele U, Stein U, Wagner E, Hild R.
    Vasa; 1985 Sep 15; 14(3):220-4. PubMed ID: 4050061
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.